Evexia Lifecare Ltd
Incorporated in 1990, Evexia Lifecare Ltd does trading of Chemicals, Agriculture Produce and other Consumer Goods[1]
- Market Cap ₹ 464 Cr.
- Current Price ₹ 2.47
- High / Low ₹ 4.40 / 2.07
- Stock P/E 499
- Book Value ₹ 2.45
- Dividend Yield 0.00 %
- ROCE 0.30 %
- ROE 0.32 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Stock is trading at 0.99 times its book value
- Company is expected to give good quarter
- Company's working capital requirements have reduced from 269 days to 149 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 1.97% over past five years.
- Promoter holding is low: 3.49%
- Company has a low return on equity of 0.61% over last 3 years.
- Company has high debtors of 307 days.
- Promoter holding has decreased over last 3 years: -39.5%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 34 | 178 | 74 | 105 | 100 | 107 | 76 | 70 | 56 | 110 | |
1 | 34 | 176 | 74 | 106 | 107 | 179 | 73 | 69 | 54 | 106 | |
Operating Profit | -0 | -0 | 1 | -0 | -1 | -6 | -72 | 2 | 1 | 2 | 4 |
OPM % | -8% | -0% | 1% | -0% | -1% | -6% | -68% | 3% | 1% | 3% | 4% |
0 | 1 | 0 | 1 | 3 | 12 | 74 | 0 | 2 | 1 | 0 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
Profit before tax | 0 | 0 | 1 | 1 | 2 | 5 | 2 | 2 | 2 | 2 | 1 |
Tax % | 31% | 41% | 32% | 33% | 30% | 29% | 33% | 60% | 56% | 28% | 36% |
0 | 0 | 1 | 0 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | |
EPS in Rs | 0.00 | 0.00 | 0.01 | 0.01 | 0.03 | 0.06 | 0.02 | 0.01 | 0.01 | 0.02 | 0.00 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 68% |
5 Years: | 2% |
3 Years: | 14% |
TTM: | 96% |
Compounded Profit Growth | |
---|---|
10 Years: | 24% |
5 Years: | -23% |
3 Years: | 3% |
TTM: | -33% |
Stock Price CAGR | |
---|---|
10 Years: | 14% |
5 Years: | -25% |
3 Years: | 12% |
1 Year: | 5% |
Return on Equity | |
---|---|
10 Years: | 1% |
5 Years: | 1% |
3 Years: | 1% |
Last Year: | 0% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 46 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 66 | 71 | 188 |
Reserves | 19 | 3 | 4 | 11 | 13 | 16 | 18 | 19 | 24 | 59 | 272 |
5 | 11 | 6 | 6 | 4 | 7 | 7 | 6 | 705 | 686 | 386 | |
4 | 35 | 147 | 128 | 146 | 139 | 56 | 41 | 52 | 67 | 75 | |
Total Liabilities | 74 | 112 | 219 | 208 | 224 | 224 | 142 | 127 | 848 | 883 | 920 |
2 | 2 | 2 | 9 | 9 | 9 | 9 | 9 | 11 | 11 | 50 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
Investments | 4 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 704 | 724 | 717 |
68 | 109 | 216 | 199 | 216 | 215 | 132 | 115 | 132 | 148 | 154 | |
Total Assets | 74 | 112 | 219 | 208 | 224 | 224 | 142 | 127 | 848 | 883 | 920 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|
4 | 11 | -116 | -12 | -0 | -3 | 2 | -6 | -3 | 17 | 0 | |
0 | 2 | 1 | -6 | 0 | 1 | -2 | 8 | -697 | -17 | -29 | |
-4 | -12 | 113 | 18 | 0 | 2 | 1 | -1 | 699 | 1 | 32 | |
Net Cash Flow | 1 | 1 | -2 | -0 | 0 | -0 | 0 | 1 | -1 | 0 | 3 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 983 | 237 | 286 | 174 | 197 | 249 | 156 | 73 | 164 | 282 | 307 |
Inventory Days | 197 | 5 | 2 | 3 | 3 | 2 | 12 | 7 | 11 | 8 | 11 |
Days Payable | 187 | 384 | 73 | 67 | 158 | 172 | 114 | 124 | 186 | 195 | 261 |
Cash Conversion Cycle | 993 | -142 | 215 | 109 | 42 | 80 | 54 | -44 | -11 | 95 | 57 |
Working Capital Days | -1,578 | 248 | 250 | 278 | 134 | 266 | 215 | 203 | 254 | 405 | 149 |
ROCE % | 0% | 2% | 1% | 3% | 6% | 2% | 3% | 0% | 0% | 0% |
Documents
Announcements
-
Closure of Trading Window
26 Jun - Trading window closed from July 1, 2025 till 48 hours post Q1 financial results announcement.
-
Revised Outcome Of The Board Meeting Held On May 30,2025
31 May - Audited FY25 financials approved; qualified audit report; new independent director appointed for 5 years.
- Financial Year For The FY24-25 31 May
-
Appointment Of Independent Director In The Company
30 May - Audited FY25 results approved; qualified audit report; new independent director appointed for 5 years.
-
Announcement under Regulation 30 (LODR)-Change in Management
30 May - Audited FY25 results with qualified audit report; appointed Ms. Mehta as independent director for 5 years.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
Company manufactures various petrochemical downstream products viz. special oils, special chemicals, petroleum sulphates and solvents
for industrial applications, such as rubber,
leather, ink and paint industries